LBP-039 Oral Alpha-V/beta-6 and Alpha-V/beta-1 Integrin Inhibitor Bexotegrast in Primary Sclerosing Cholangitis: Updated 12-Week Interim Safety and Efficacy Analysis of the INTEGRIS-PSC Phase 2a Trial
Journal of hepatology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要